Pharma Stocks Outlook: Analyst Reveals His Top Pharma Picks After The Selloff

Pharma stocks have witnessed profit booking after strong outperformance in recent months with several companies facing a correction. However, selected stocks are showing signs of recovery. Aditya Agarwal, Head of Investment at Coheron Wealth, identifies Dr Reddy’s Laboratories as his top pick in the pharma sector with potential targets of ₹1,340 - ₹1,380 and a stop-loss at ₹1,200. He also sees scope for a short-covering rally in Lupin, which could move towards ₹2,100 - ₹2,150 after its recent decline. The outlook highlights stock-specific opportunities amid continued volatility across pharma, mid-cap and small-cap segments.